Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy

Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy

Blog Article

Globally, breast cancer is one of the most prevalent blue rottnest island daisy diseases, inducing critical intimidation to human health.Lipid-based nanomaterials have been successfully demonstrated as drug carriers for breast cancer treatment.To date, the development of a better drug delivery system based on lipid nanomaterials is still urgent to make the treatment and diagnosis easily accessible to breast cancer patients.In a drug delivery system, lipid nanomaterials have revealed distinctive features, including high biocompatibility and efficient drug delivery.

Specifically, a targeted drug delivery system based on lipid nanomaterials has inherited the advantage of optimum dosage and low side effects.In this review, insights on currently used potential lipid-based nanomaterials are collected and introduced.The review sheds light on conjugation, targeting, diagnosis, treatment, and clinical significance of lipid-based nanomaterials interlock ettore to treat breast cancer.Furthermore, a brighter side of lipid-based nanomaterials as future potential drug delivery systems for breast cancer therapy is discussed.